Signal Pharmaceuticals' Unattributed VC Round

Signal Pharmaceuticals raised a round of funding on , . Investors include InterWest Partners.

Signal was established to develop a new generation of small molecule pharmaceuticals based on recent discoveries about the way genes are regulated. The company's products used gene control - essential…

Articles about Signal Pharmaceuticals' Unattributed VC Round: